MARKET

NAII

NAII

Natural Alt Intl
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.77
+0.12
+1.77%
Opening 14:08 07/09 EDT
OPEN
6.75
PREV CLOSE
6.65
HIGH
6.77
LOW
6.75
VOLUME
5.53K
TURNOVER
--
52 WEEK HIGH
11.83
52 WEEK LOW
4.750
MARKET CAP
45.94M
P/E (TTM)
-12.1727
1D
5D
1M
3M
1Y
5Y

NAII News

More
Natural Alternatives reports Q3 results
Natural Alternatives (NASDAQ:NAII): Q3 GAAP EPS of -$0.61. Revenue of $25.48M (-28.1% Y/Y) Press Release
seekingalpha · 05/15 01:36
Natural Alternatives International, Inc. Announces 2020 Q3 and YTD Results
Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced a net loss of $4.0 million, or $0.61 per diluted share, for the quarter ended March 31, 2020
PR Newswire · 05/14 20:30
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Natural Alternatives International, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
PR Newswire · 04/07 12:03
INVESTOR ALERT: Fields Kupka & Shukurov LLP Is Investigating Natural Alternatives International, Inc. for Potential Breach of Fiduciary Duty Claims
GlobeNewswire · 04/06 18:29
Our Take On Natural Alternatives International, Inc.'s (NASDAQ:NAII) CEO Salary
Simply Wall St. · 03/20 12:57
Natural Alternatives International, Inc. Announces Increase in its Stock Repurchase Plan
PR Newswire · 03/19 01:26
CarnoSyn® Brands Enters Third Year of Strategic Partnership with TEST Football Academy
PR Newswire · 03/06 22:01
Natural Alternatives Q2 EPS $0.07 Down From $0.31 YoY, Sales $29.103M Down From $36.043M YoY
Natural Alternatives (NASDAQ:NAII) reported quarterly earnings of $0.07 per share. This is a 77.42 percent decrease over earnings of $0.31 per share from the same period last year. The company reported $29.103 million
Benzinga · 02/11 21:34

Industry

Pharmaceuticals
-0.87%
Pharmaceuticals & Medical Research
-0.68%

Hot Stocks

Symbol
Price
%Change

About NAII

Natural Alternatives International, Inc. is a formulator, manufacturer and marketer of nutritional supplements. The Company operates through three segments: private-label contract manufacturing, patent and trademark licensing, and branded products. The private-label contract manufacturing segment primarily relates to the provision of private-label contract manufacturing services to companies that market and distribute nutritional supplements and other healthcare products. The patent and trademark licensing segment primarily includes direct raw material sales and royalty income from its license and supply agreements associated with the sale and use of beta-alanine under its CarnosSyn trade name. The branded products segment relates to the marketing and distribution of branded nutritional supplements and consists primarily of the products sold under its Pathway to Healing product line.
More

Webull offers kinds of Natural Alternatives International, Inc. stock information, including NASDAQ:NAII real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NAII stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NAII stock methods without spending real money on the virtual paper trading platform.